Staff Members - Benha University
Usefulness of serum fetuin-A level as a marker of erectile dysfunction
International Journal of Impotence Research • 2017
Publication Information
Authors
W Kandeel1, W El-Shaer1, A Sebaey1, AA Abou-Taleb1, A Fathy1, B Elmohamady1 and AI Mansour2
Keywords
Not Available
Journal
International Journal of Impotence Research
Publisher
Not Available
Volume
2017) 00,
Issue
1
Pages
1-5
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
This study aimed to evaluate the correlation between serum levels of fetuin-A and the presence and severity of erectile dysfunction
(ED) in Egyptian population. The study was performed on 60 ED patients and 20 age—matched healthy controls. A comprehensive
medical history and complete physical examination were obtained and performed in all participants. ED and its severity were
assessed via International Index of Erectile Function (IIEF-5). Doppler ultrasound, fasting blood glucose level, complete lipid profile,
serum total testosterone (TT) and serum fetuin-A were performed. Our results revealed that there were no statistically significant
differences between the ED group and the controls regarding body mass index, fetal bovine serum, cholesterol, low-density
lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride (TG). However, IIEF-5 and serum TT levels were significantly lower
in ED patients than controls. Regarding serum fetuin-A, our data demonstrated that ED patients had significantly lower serum
fetuin-A levels than controls. In addition, patients with severe ED had lower fetuin-A levels than moderate and mild ED (Po0.001).
Serum fetuin-A levels are positively correlated with cholesterol, LDL, TG and IIEF-5 and negatively correlated with HDL. In
conclusion, serum fetuin-A level could be a potentially useful and sensitive biomarker for ED diagnosis.
(ED) in Egyptian population. The study was performed on 60 ED patients and 20 age—matched healthy controls. A comprehensive
medical history and complete physical examination were obtained and performed in all participants. ED and its severity were
assessed via International Index of Erectile Function (IIEF-5). Doppler ultrasound, fasting blood glucose level, complete lipid profile,
serum total testosterone (TT) and serum fetuin-A were performed. Our results revealed that there were no statistically significant
differences between the ED group and the controls regarding body mass index, fetal bovine serum, cholesterol, low-density
lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride (TG). However, IIEF-5 and serum TT levels were significantly lower
in ED patients than controls. Regarding serum fetuin-A, our data demonstrated that ED patients had significantly lower serum
fetuin-A levels than controls. In addition, patients with severe ED had lower fetuin-A levels than moderate and mild ED (Po0.001).
Serum fetuin-A levels are positively correlated with cholesterol, LDL, TG and IIEF-5 and negatively correlated with HDL. In
conclusion, serum fetuin-A level could be a potentially useful and sensitive biomarker for ED diagnosis.